The promise of the anti-idiotype concept
A basic tenet of antibody-based immunity is their specificity to antigenic determinates from foreign pathogen products to abnormal cellular components such as in cancer. However, an antibody has the potential to bind to more than one determinate, be it an antigen or another antibody. These observati...
Main Authors: | , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Frontiers Media S.A.
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526099/ |
id |
pubmed-3526099 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-35260992012-12-24 The promise of the anti-idiotype concept Kieber-Emmons, Thomas Monzavi-Karbassi, Bejatohlah Pashov, Anastas Saha, Somdutta Murali, Ramachandran Kohler, Heinz Immunology A basic tenet of antibody-based immunity is their specificity to antigenic determinates from foreign pathogen products to abnormal cellular components such as in cancer. However, an antibody has the potential to bind to more than one determinate, be it an antigen or another antibody. These observations led to the idiotype network theory (INT) to explain immune regulation, which has wax and waned in enthusiasm over the years. A truer measure of the impact of the INT is in terms of the ideas that now form the mainstay of immunological research and whose roots are spawned from the promise of the anti-idiotype concept. Among the applications of the INT is understanding the structural implications of the antibody-mediated network that has the potential for innovation in terms of rational design of reagents with biological, chemical, and pharmaceutical applications that underlies concepts of reverse immunology which is highlighted herein. Frontiers Media S.A. 2012-12-19 /pmc/articles/PMC3526099/ /pubmed/23267437 http://dx.doi.org/10.3389/fonc.2012.00196 Text en Copyright © Kieber-Emmons, Monzavi-Karbassi, Pashov, Saha, Murali and Kohler. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Kieber-Emmons, Thomas Monzavi-Karbassi, Bejatohlah Pashov, Anastas Saha, Somdutta Murali, Ramachandran Kohler, Heinz |
spellingShingle |
Kieber-Emmons, Thomas Monzavi-Karbassi, Bejatohlah Pashov, Anastas Saha, Somdutta Murali, Ramachandran Kohler, Heinz The promise of the anti-idiotype concept |
author_facet |
Kieber-Emmons, Thomas Monzavi-Karbassi, Bejatohlah Pashov, Anastas Saha, Somdutta Murali, Ramachandran Kohler, Heinz |
author_sort |
Kieber-Emmons, Thomas |
title |
The promise of the anti-idiotype concept |
title_short |
The promise of the anti-idiotype concept |
title_full |
The promise of the anti-idiotype concept |
title_fullStr |
The promise of the anti-idiotype concept |
title_full_unstemmed |
The promise of the anti-idiotype concept |
title_sort |
promise of the anti-idiotype concept |
description |
A basic tenet of antibody-based immunity is their specificity to antigenic determinates from foreign pathogen products to abnormal cellular components such as in cancer. However, an antibody has the potential to bind to more than one determinate, be it an antigen or another antibody. These observations led to the idiotype network theory (INT) to explain immune regulation, which has wax and waned in enthusiasm over the years. A truer measure of the impact of the INT is in terms of the ideas that now form the mainstay of immunological research and whose roots are spawned from the promise of the anti-idiotype concept. Among the applications of the INT is understanding the structural implications of the antibody-mediated network that has the potential for innovation in terms of rational design of reagents with biological, chemical, and pharmaceutical applications that underlies concepts of reverse immunology which is highlighted herein. |
publisher |
Frontiers Media S.A. |
publishDate |
2012 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526099/ |
_version_ |
1611941532016836608 |